In this commentary, an expert explains how high-dose IL-2 continues to have a role in the management of resistant or progressive melanoma and discusses evolving ways to incorporate IL-2 therapy into melanoma care.
This downloadable slideset from an ondemand webcast provides an overview of the current treatment landscape in advanced melanoma including evidence on targeted therapy, immunotherapy, and combinations.
This downloadable slideset from an ondemand webcast offers insight into best practices for the management of adverse events associated with different classes of agents used for advanced melanoma including targeted therapy, immunotherapy, and high-dose IL2 therapy.
This downloadable slideset from an ondemand webcast explores the role of cytokine therapy and emerging strategies in the management of resistant or progressive melanoma.
Download this summary slideset with a brief review the current treatment landscape in advanced melanoma and the role of cytokine-based therapy in progressive or resistant melanoma.
Learn how experts leverage cytokine therapy for optimal treatment of patients with advanced melanoma in this on-demand webcast capturing a live CCO webinar.